Spherical Endometrial Ablation Device.
IUB™ SEAD® is an innovative, non-hormonal treatment paradigm for women suffering from abnormal uterine bleeding and/or heavy menstrual bleeding, a problem affecting 1 of 5 women globally.
IUB™ SEAD® is a market game changer through simplicity, cost effectiveness and new and innovative yet gentle “substance-derived ablation” technology moving away from harmful hormones or debilitating and aggressive procedures and even hysterectomies.
OCON has recently begun developing a new product, IUB™ PRIMA®, which will enable sustained release of a variety of drugs in the uterus over a fixed and defined period of time to target therapy areas such as endometriosis (1 in 10 women), myomas / uterine fibroids (7 to 8 in 10 women), heavy menstrual bleeding (1 in 4 women) and other areas like menopause – delivered directly through the uterus moving away from systemic side effects
1 ongoing vigilance reporting for IUB™ Ballerine, OCON Medical Ltd.